
Hybrid Neuroendocrine Cancers: Pathology, Grade Transformation, and Emerging Therapies
NETCast
00:00
Tracking Progression in Hybrid Tumors
Shagufta Shaheen recommends cross-sectional imaging, DOTATATE/FDG PET pairing, and re-biopsy to identify progressing component.
Play episode from 16:33
Transcript


